Skip to main content

Table 3 Comparison of in vivo long-term reproduction studies with mammals and fish with results from receptor-based in vitro assays

From: Screening for potential endocrine disruptors in fish: evidence from structural alerts and in vitro and in vivo toxicological assays

Compound

CAS no.

Mechanism

Mammalian reproductive toxicology

Fish in vivo effects

Reporter gene (cell) assays

Receptor-binding studies

Fish full and partial life-cycle (FLC) test

Fish screening assay (FSA)

Potency relative to positive control

Potency relative to positive control

In vivo ED effect LOAEL

NOEC/EC10 population

NOEC indicator parameter

Effect

ER agonist

AR agonist

AR antagonist

ER

AR

17-α Ethinylestradiol

57-63-6

ER agonist

Pos.-control in screening assays (OECD 440)

0.3 ng/L, fertilization rate, delayed oviposition [41]

1 ng/L, ovotestis [42]

VTG increase [27]

Very active [43]

 

No [28]

Very active [5]

Moderate [21]

17-β Estradiol

50-28-2

ER agonist

0.0025 mg/kg BW

2.9 ng/L, fertilization rate, juvenile growth [44]

2.9 ng/L, VTG induction, males [44]

 

Very active [45]

Moderate [28]

Active [18]

Very active [5]

Active [21]

Tamoxifen

10540-29-1

ER antagonist

0.00012 mg/kg BW

1.6 µg/L, fertilization rate [27]

1.6 µg/L, VTG decrease, females [27]

VTG decrease [27]

Moderate [43]

 

Moderate [46]

Very active [21]

Active [46]

Genistein

446-72-0

ER agonist, enzyme inhibitor: aromatase

1.25 mg/kg BW

1.3 µg/L, fertilization rate, delayed oviposition [27]

  

Moderate [47]

  

Very active [21]

Moderate [21]

Methyl-testosterone

58-18-4

AR agonist

 

10 ng/L, sex ratio [48]

<0.4 ng/L, VTG decrease, females [48]

 

Active [49]

Active [49]

  

Very active [21]

17β-Trenbolone

10161-33-8

AR agonist

1.68 mg/kg BW

3 ng/L, sex ratio [50]

<1 ng/L, histology: egg debris [50]

VTG and 11-keto-testosterone: no effect [27]

 

Active[28]

  

Very active [21]

Flutamide

13311-84-7

AR antagonist

2.5 mg/kg BW

189 µg/L, egg production [27]

435 µg/L, VTG decrease, females, 11-keto-testosterone: increase [27]

VTG no effect, 11-keto-testosterone: increase [27]

 

Weak [28]

Very active [28]

 

Moderate [21]

Bisphenol A

80-05-7

ER agonist

0.0002 mg/kg BW

390 µg/L, fertilization rate, delayed oviposition [51] 160 µg/L, hatching rate of F1 generation [52]

1 µg/L, histology: testis, VTG increase, males [52]

VTG increase, 11-keto-testosterone: decrease [27]

Moderate [53]

Very weak [54]

Active [18]

Moderate [5, 21]

Moderate [21]

4-tert-Pentylphenol

80-46-6

ER agonist

 

100 µg/L, fertilization rate, sex ratio [55]

<51 µg/L, VTG increase, males [55]

   

Active [18]

Moderate [5, 21]

Moderate [21]

4-tert-Octylphenol

140-66-9

ER agonist

 

11 µg/L, fertilization rate, delayed oviposition [27]

 

VTG increase, 11-keto-testosterone: decrease [27]

Moderate [56]

Very weak [57]

Active [18]

Moderate [5, 21]

Moderate [21]

4-Nonylphenol

84852-15-3

ER agonist

10 mg/kg BW

8.2 µg/L, sex ratio, survival rate [58]

4.2 µg/L, gonadosomatic index [58]

 

Moderate [59]

Very weak [60]

Very weak [60]

Moderate [21]

Moderate [21]

Prochloraz (DMI fungicide)

67747-09-5

Aromatase inhibitor

 

64 µg/L, sex ratio [61]

<16 µg/L, VTG increase, males [61]

VTG decrease [27]

Very weak [62]

 

Very weak [62]

  
  1. Mammalian reproductive toxicology from: http://cefic-lri.org/lri_toolbox/fedtex/, http://www.fraunhofer-repdose.de/
  2. Relative potencies in receptor-based in vitro assays: substances were categorized based on their in vitro potencies in individual tests, relative receptor-binding affinities, or effect concentrations relative to positive controls, ethinylestradiol (estrogenic) or testosterone (androgenic), respectively (Table 1)
  3. LOAEL lowest observed adverse effect level, NOEC no observed effect concentration, ER estrogen receptor, AR androgen receptor, VTG vitellogenin, DMI fungicide demethylation inhibitor (sterol synthesis inhibitor)